Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
This study aims to investigate whether semaglutide can reduce the progression of noncalcified coronary atherosclerotic plaque volume, as measured by serial coronary computed tomography angiography (CTA), over a one-year period compared to a placebo, in individuals with diabetes
The sample was mixed with internal standards and derivatized with butanol-HCl
Not in animal models
US$ 25.57
US$ 24.24
US$ 29.66
US$ 22.55
US$ 27.77
US$ 22.76
US$ 27.38
US$ 26.65
US$ 23.92
